PGP and neoplasm: In this context, the activity of the efflux transporters P-gP and BCRP plays a pivotal role modulating the quantity of drug reaching the systemic circulation, and hence the tumor cell, as well as the amount of drug that is delivered to the intracellular molecular targets.